Serum Institute & Bharat Biotech's Covid vaccines, currently authorised only for emergency use in India, were granted approval by DCGI on certain conditions, official source said.
India recently resumed Covid vaccine supply to the UN-backed COVAX with the govt allowing SII to export 50 lakh doses of Covishield to Nepal, Tajikistan, Bangladesh and Mozambique.
In a production plan submitted to the Centre in May, SII’s director communicated that the production of Covishield would be ramped up to 10 crore each in August, September, said sources.
The study, conducted by Christian Medical College in Vellore, aims to assess whether a person can be given two different Covid vaccine shots to complete the inoculation course.
Without a data system, India is bound to land in a situation where minimal to nil insights are gained from possibly the largest vaccination drive in the world.
The claim that VB-GRAMG provides an employment guarantee is incorrect. The only guarantee is to 'empower' the Centre to allow partial implementation in notified areas alone.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS